Market›Health Care›Health Care Equipment & Supplies›Health Care Supplies
BAUSCH LOMB CORP

BLCO

$15.82May 06, 2022 – Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Supplies$5.74B
MVM
-$56.7M
TD Variance
-0.188

Every news event mapped to its market reaction — 154 events, 48 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-09-16+19.2%newsMarketWatchBausch + Lomb’s stock soars 14% on report company is considering selling itself - MarketWatch
2024-02-21+16.5%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2024-02-21+16.5%earningsInvestopediaBausch + Lomb Stock Jumps After Better-Than-Expected Earnings, Guidance - Investopedia
2024-02-20+16.5%newsFortuneBausch + Lomb (BLCO): Company Profile, Stock Price, News, Rankings - Fortune
2025-04-30-16.3%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2024-09-17+12.6%newsCNBCOp-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors - CNBC
2023-02-15+11.0%legalSEC EDGARBLCO 8-K: 5.02, 7.01 (SEC Filing)
2022-05-09-9.3%newsThe Globe and MailBausch Lomb Corporation (BLCO-T) Stock Price and News - The Globe and Mail
2025-02-06-8.7%newsBloomberg.comBausch + Lomb Sinks After Disclosing It Won’t Go Private Now - Bloomberg.com
2025-06-27+6.8%legalSEC EDGARBLCO 8-K: 1.01, 2.03, 8.01 (SEC Filing)
2022-05-10-6.7%legalSEC EDGARBLCO 8-K: 1.01, 5.03, 8.01 (SEC Filing)
2022-05-31-6.6%newsChartMillBLCO Stock Price, Quote & Chart | BAUSCH + LOMB CORP (NYSE:BLCO) - ChartMill
2024-10-14+6.5%newsInvestopediaBausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid - Investopedia
2025-07-30-6.5%earningsSeeking AlphaBausch + Lomb Corporation 2025 Q2 - Results - Earnings Call Presentation
2025-07-30-6.5%earningsSeeking AlphaBausch + Lomb reports mixed Q2 results; updates FY25 outlook
2025-07-30-6.5%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2026-02-13+5.7%newsAD HOC NEWSThe Truth About Bausch + Lomb Corp: Is This Eye-Care Giant Quietly Winning While No One’s Looking? - AD HOC NEWS
2026-03-31+5.6%earningsMarketBeatBausch + Lomb Corporation (NYSE:BLCO) Receives Average Rating of "Hold" from Analysts - MarketBeat
2026-03-12-5.4%earningsThe Motley FoolEye Care Giant Posts $5.1 Billion in Revenue as One Investor Builds Major Position - The Motley Fool
2024-05-01-5.3%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2023-06-30+5.0%legalSEC EDGARBLCO 8-K: 8.01 and (SEC Filing)
2022-08-04+4.9%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2026-04-21-4.6%earningsMotley FoolBausch + Lomb (BLCO) Q3 2025 Earnings Transcript
2026-04-21-4.6%earningsMotley FoolBausch + Lomb (BLCO) Q4 2025 Earnings Transcript
2026-04-21-4.6%newsAD HOC NEWSBausch + Lomb Corp stock (CA07174N1090): Why Google Discover changes matter more now - AD HOC NEWS
2025-06-17-4.5%newsSeeking AlphaBausch + Lomb Has Promising Growth, But Lower Entry Points Likely Loom (NYSE:BLCO) - Seeking Alpha
2022-05-16-4.4%newsStock TitanLatest BLCO News - Bausch + Lomb Announces Published Review Ex... - Stock Titan
2025-10-13+4.2%legalDirectorsTalk InterviewsBausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 6.84% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
2025-06-10+4.1%legalSEC EDGARBLCO 8-K: 8.01 and (SEC Filing)
2025-06-10+4.1%newssimplywall.stBausch + Lomb (NYSE:BLCO) Use Of Debt Could Be Considered Risky - simplywall.st
2026-04-06-4.0%newsStock TitanDry eye and cataract data lead Bausch + Lomb's 45-study ASCRS lineup - Stock Titan
2026-04-06-4.0%newsCổng thông tin điện tử Tỉnh Sơn LaCan Bausch Lomb (BLCO) Stock Recover Now | Price at $16.39, Down 0.64% - Crowd Sentiment Stocks - Cổng thông tin điện tử Tỉnh Sơn La
2026-02-16+3.9%earningsTradingViewBausch + Lomb (BLCO) Q4 Earnings: What To Expect - TradingView
2022-07-27-3.9%legalSEC EDGARBLCO 8-K: 5.02 (SEC Filing)
2025-11-10+3.9%newsStock TitanBausch + Lomb (NYSE: BLCO) ONE by ONE Recycling totals 691,180 lbs, 114,037,136 units - Stock Titan
2024-02-28-3.8%legalSEC EDGARBLCO 8-K: 5.02, 7.01 (SEC Filing)
2024-05-24+3.6%M&ASeeking AlphaBausch + Lomb's Bet-The-Farm Xiidra Acquisition Is Looking Questionable, But Miebo Could Make The Stock A Winner - Seeking Alpha
2025-11-14-3.4%analystSeeking AlphaBausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation - Analyst/Investor Day - Slideshow
2022-06-08-3.4%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2025-07-23-3.2%legalSEC EDGARBLCO 8-K: 5.02 (SEC Filing)
2025-10-20+3.2%executiveSeeking AlphaSplitting Cooper's contact lens, women's health business makes sense - analyst
2025-10-20+3.2%executiveSeeking AlphaCooper Cos. gains after report activist Jana takes stake
2026-02-17+3.1%newsInvesting.comBausch + Lomb stock hits 52-week high at $17.87 - Investing.com
2024-03-26+3.0%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2023-04-12-2.8%legalSEC EDGARBLCO 8-K: 5.02 and (SEC Filing)
2025-02-19-2.6%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2023-09-11+2.6%legalSEC EDGARBLCO 8-K: 8.01 and (SEC Filing)
2025-05-21-2.6%legalSEC EDGARBLCO 8-K: 8.01 and (SEC Filing)
2026-04-02-2.6%legalStock TitanBLCO SEC Filings - Bausch + Lomb Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
2026-01-02-2.5%newsSeeking AlphaBausch + Lomb completes refinancing of outstanding term B loans
2026-01-02-2.5%legalSEC EDGARBLCO 8-K: 1.01, 2.03, 8.01 (SEC Filing)
2025-01-12-2.4%newsYahoo FinanceIs Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20? - Yahoo Finance
2025-12-11+2.3%analystSeeking AlphaIntuitive Surgical downgraded as Citi previews 2026 in MedTech
2025-12-11+2.3%newsFinvizWhy Bausch + Lomb (BLCO) Stock Is Trading Up Today - Finviz
2023-09-29-2.3%legalSEC EDGARBLCO 8-K: 1.01, 2.01, 2.03 (SEC Filing)
2026-04-22-2.2%earningsMotley FoolBausch Health (BHC) Q3 2024 Earnings Transcript
2026-04-22-2.2%newsSimply Wall St.Is It Time To Reconsider Bausch + Lomb (BLCO) After Its 28% One-Year Rally?
2026-04-22-2.2%newsBusiness WireBausch + Lomb Releases 2025 Sustainability Impact Report
2026-04-22-2.2%earningsInsider MonkeyWhy Bausch + Lomb (BLCO) Just Strengthened Something Beyond Earnings
2026-04-22-2.2%earningsInsider MonkeyWhy Bausch + Lomb (BLCO) Just Strengthened Something Beyond Earnings - Insider Monkey
2026-04-22-2.2%newsStock TitanBausch + Lomb targets net zero by 2050, trims lens plastic waste - Stock Titan
2024-11-01-2.2%legalSEC EDGARBLCO 8-K: 1.01, 2.03 (SEC Filing)
2024-04-19+2.2%analysteToroBLCO Stock Price | Analyst Target 18.00 & Hold Consensus - eToro
2025-11-18-2.1%analystSeeking AlphaBausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation - Analyst/Investor Day Transcript
2025-01-20-2.0%newsChartMillBLCO.CA Stock Price, Quote & Chart | BAUSCH + LOMB CORP (TSX:BLCO) - ChartMill
2025-12-02+1.9%analystSeeking AlphaBausch + Lomb upgraded at Morgan Stanley on pipeline
2025-12-02+1.9%newsFinvizWhy Bausch + Lomb (BLCO) Stock Is Up Today - Finviz
2025-12-02+1.9%analystSeeking AlphaBausch + Lomb upgraded at Morgan Stanley on pipeline - Seeking Alpha
2026-03-16+1.9%newsAD HOC NEWSBausch + Lomb Corp Stock (ISIN: CA07174N1090) Faces Headwinds Amid Vision Care Demand Shifts - AD HOC NEWS
2025-06-18+1.8%legalSEC EDGARBLCO 8-K: 8.01 and (SEC Filing)
2024-05-22+1.8%newsSeeking AlphaBausch + Lomb Corporation: Spin-Off Ready To Fly Troubled Nest And Find Upside (NYSE:BLCO) - Seeking Alpha
2025-12-03-1.8%newsSeeking AlphaBausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents at Citi Annual Global Healthcare Conference 2025 Transcript
2025-12-03-1.8%newsThe Motley FoolBLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point? - The Motley Fool
2026-04-23-1.8%newsBusiness WireBausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration
2026-04-23-1.8%newsStock Titan20 studies examine B vitamins for macular degeneration as new formula hits U.S. - Stock Titan
2026-04-16-1.8%newsBusiness WireBausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program
2026-04-16-1.8%newsStock TitanUsed contacts and lens packs add up: 725,000 pounds recycled - Stock Titan
2026-03-03-1.8%newsStock Titan[Form 4] Bausch & Lomb Corp Insider Trading Activity - Stock Titan
2026-03-03-1.8%newsStock TitanBausch & Lomb (NYSE: BLCO) director buys shares, gets RSUs - Stock Titan
2022-06-23-1.7%legalSEC EDGARBLCO 8-K: 1.01, 5.02 (SEC Filing)
2026-03-17-1.7%analystInvesting.comRBC reiterates Bausch & Lomb stock rating on DED rival delay - Investing.com
2026-03-17-1.7%analystMeykaRBC Maintains Outperform on Bausch + Lomb Corporation (BLCO) Mar 17, 2026 - Meyka
2026-03-06-1.7%newsTradingViewIntegra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know - TradingView
2024-05-29+1.7%legalSEC EDGARBLCO 8-K: 5.02 and 5.07 (SEC Filing)
2025-02-21+1.7%newsSeeking AlphaBausch + Lomb: Solid 2024 Results, But Let's Address The Elephant In The Room (BLCO) - Seeking Alpha
2023-11-01+1.6%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2023-08-29-1.6%legalSEC EDGARBLCO 8-K: 5.02 (SEC Filing)
2025-09-19-1.5%analystSeeking AlphaBausch + Lomb: There Are Better Opportunities Out There (Rating Downgrade)
2025-09-19-1.5%analystSeeking AlphaBausch + Lomb: There Are Better Opportunities Out There (Rating Downgrade) - Seeking Alpha
2023-05-03+1.5%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2025-09-08+1.5%newsSeeking AlphaBausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
2026-01-12+1.4%newsSeeking AlphaBausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
2026-04-03-1.4%newsUBND thành phố Hải PhòngBLCO Stock Analysis: Bausch and Lomb Corp Common Shares 1.14% dip at 16.49 USD - UBND thành phố Hải Phòng
2026-04-07-1.4%newsStock TitanBausch + Lomb brings full-range vision lens implant to Europe - Stock Titan
2022-11-02-1.4%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2026-01-25-1.2%newsAD HOC NEWSBausch + Lomb Corp: Eyes On The Numbers As BLCO Tests Investor Patience - AD HOC NEWS
2022-07-20+1.2%legalSEC EDGARBLCO 8-K: 5.02, 7.01 (SEC Filing)
2025-12-04-1.1%newsYahoo FinanceWall Street Cautious on ​Bausch + Lomb Corporation (BLCO), Here’s Why - Yahoo Finance
2025-12-22-1.1%legalSEC EDGARBLCO 8-K: 5.02 (SEC Filing)
2026-02-19+1.1%earningsSeeking AlphaBausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats
2026-02-19+1.1%earningsSeeking AlphaBausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats (NYSE:BLCO) - Seeking Alpha
2024-12-06+1.0%newsSeeking AlphaBausch + Lomb And Bausch Health: Some Incremental Progress As We Wait For Sale News (BLCO) - Seeking Alpha
2023-11-07-1.0%legalSEC EDGARBLCO 8-K: 5.02 (SEC Filing)
2025-08-18+1.0%legalSEC EDGARBLCO 8-K: 1.02, 5.02, 7.01 (SEC Filing)
2026-03-02-0.9%earningsDirectorsTalk InterviewsBausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 1.87% Upside with Robust Revenue Growth - DirectorsTalk Interviews
2026-03-02-0.9%newsStock TitanBausch & Lomb (NYSE: BLCO) SVP disposes shares for taxes - Stock Titan
2026-03-24+0.9%newsSeeking AlphaBausch + Lomb Corporation (BLCO) Discusses Glaucoma Pipeline Focus With Updates on BL1107 and Elios Transcript
2026-03-30+0.9%earningsStock TitanBausch + Lomb to webcast Q1 results and business update April 29 - Stock Titan
2026-03-30+0.9%newsTipRanksBausch + Lomb Sets Date for First-Quarter 2026 Results and Investor Call - TipRanks
2026-04-13-0.9%newsGlobeNewswireMacugen (Bausch + Lomb: pegaptanib sodium) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
2022-05-17-0.8%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2023-08-02-0.8%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2026-03-23-0.8%newsSeeking AlphaBausch + Lomb Corporation (BLCO) Discusses Glaucoma Pipeline Focus With Updates on BL1107 and Elios - Slideshow
2026-03-23-0.8%newsSeeking AlphaBausch + Lomb unveils pivotal data for ELIOS System for glaucoma
2026-03-23-0.8%newsSeeking AlphaBausch + Lomb Corporation (BLCO) Discusses Glaucoma Pipeline Focus With Updates on BL1107 and Elios - Slideshow (NYSE:BLCO) 2026-03-23 - Seeking Alpha
2026-03-23-0.8%newsStock TitanGlaucoma laser left 82% of patients medication-free in U.S. trial - Stock Titan
2026-02-18-0.7%earningsSeeking AlphaBausch + Lomb outlines 2026 revenue target of $5.475B with margin expansion driven by dry eye growth
2026-02-18-0.7%earningsSeeking AlphaBausch + Lomb Corporation (BLCO) Q4 2025 Earnings Call Transcript
2026-02-18-0.7%earningsSeeking AlphaBausch + Lomb Corporation 2025 Q4 - Results - Earnings Call Presentation
2026-02-18-0.7%newsSeeking AlphaBausch + Lomb reports mixed results; initiates FY26outlook
2026-02-18-0.7%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2026-02-18-0.7%newsTradingViewBLCO Stock Price and Chart — NYSE:BLCO - TradingView
2026-02-18-0.7%earningsTradingViewBausch + Lomb’s (NYSE:BLCO) Q4 CY2025: Beats On Revenue - TradingView
2025-05-06+0.7%newsPR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch + Lomb Corporation - BLCO - PR Newswire
2025-10-29+0.7%earningsSeeking AlphaBausch + Lomb Corporation 2025 Q3 - Results - Earnings Call Presentation
2025-10-29+0.7%earningsSeeking AlphaBausch + Lomb outlines Vision '27 strategy while maintaining 2025 revenue guidance at $5.05B–$5.15B
2025-10-29+0.7%earningsSeeking AlphaBausch + Lomb Corporation (BLCO) Q3 2025 Earnings Call Transcript
2025-10-29+0.7%earningsSeeking AlphaBausch + Lomb beats bottom-line estimates; updates FY25 outlook
2025-10-29+0.7%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2023-04-26+0.6%legalSEC EDGARBLCO 8-K: 5.02 and 5.07 (SEC Filing)
2022-12-22+0.6%legalSEC EDGARBLCO 8-K: 5.02, 7.01 (SEC Filing)
2023-07-07+0.6%legalSEC EDGARBLCO 8-K: 1.01 and (SEC Filing)
2025-07-31+0.5%earningsSeeking AlphaBausch + Lomb raises 2025 revenue guidance to $5.15B as dry eye and contact lens growth accelerate
2025-07-31+0.5%earningsSeeking AlphaBausch + Lomb Corporation (BLCO) Q2 2025 Earnings Call Transcript
2026-04-08+0.4%legalStock TitanEye surgeons get a faster retinal cutter as FDA clears Bausch + Lomb update - Stock Titan
2026-04-08+0.4%newsAD HOC NEWSBausch + Lomb Corp stock: Eye health innovation drives undervaluation debate - AD HOC NEWS
2025-12-15+0.4%analystSeeking AlphaBausch + Lomb: I Need To See Stability Before Upgrading This Name
2025-12-15+0.4%analystSeeking AlphaBausch + Lomb: I Need To See Stability Before Upgrading This Name (BLCO) - Seeking Alpha
2026-03-09-0.4%newsStock TitanInside Bausch + Lomb’s glaucoma webinar on new treatments - Stock Titan
2026-01-13-0.3%newsSeeking AlphaBausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
2025-12-23-0.3%newsStock TitanTop eye-care leaders to speak at J.P. Morgan's big healthcare event - Stock Titan
2023-09-14+0.3%legalSEC EDGARBLCO 8-K: 8.01 and (SEC Filing)
2024-07-31-0.2%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2023-06-01-0.2%legalSEC EDGARBLCO 8-K: 5.02 and (SEC Filing)
2025-12-12+0.2%newsSeeking AlphaBausch + Lomb allocates $2.8 bln in new term loans to refinance existing debt
2025-12-12+0.2%legalSEC EDGARBLCO 8-K: 8.01 and (SEC Filing)
2026-04-19-0.2%newsAD HOC NEWSBausch + Lomb Corp stock (CA07174N1090): Why Google Discover changes matter more now - AD HOC NEWS
2025-12-17-0.1%legalSEC EDGARBLCO 8-K: 5.02 and (SEC Filing)
2024-10-30-0.1%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2023-02-22-0.0%legalSEC EDGARBLCO 8-K: 2.02 and (SEC Filing)
2026-02-27-0.0%earningsYahoo FinanceBausch + Lomb (BLCO) Reports Record Q4 2025 Financial Results Driven by Strong Pharmaceutical and Vision Care Growth - Yahoo Finance
2026-04-24—earningsMT NewswiresBausch + Lomb's Q1 Likely Saw Revenue Tailwinds From ForEx, RBC Says
2026-04-24—legalStock TitanBLCO SEC Filings - Bausch + Lomb Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
2022-05-06—expansionMultiVuBAUSCH + LOMB CORPORATION LAUNCHES AS A PUBLICLY TRADED COMPANY - MultiVu
tickerdossier.comtickerdossier.substack.com